The state service of Ukraine on drugs and drug control has imposed a ban on preparatas the treatment of macular (Central retina) OekoTex.
In particular, Director of Allergan UKRAINE, representing the interests of the applicant and the manufacturer of the drug is OZURDEX, the company Allergan PHARMACEUTICALS IRELAND, Castlebar ROAD, Westport, KO. Mine, IRELAND (ALLERGAN PHARMACEUTICALS IRELAND, CASTLEBAR ROAD, WESTPORT, CO. MAYO, IRELAND) on the territory of Ukraine, Alexander Uskov said, ctose information regarding the recommendations of the European Agency of medicines (EMA) and regulatory bodies in the field of quality control of medicines of the Republic of Ireland (HPRA) for use of the medicine OZURDEX in the countries of the European Union is provided for informational purposes only physicians and currently is not a recommendation for use on the territory of Ukraine.
About the drug
The OZURDEX is used to treat inflammation of the eye, molecular edema, as the implant for intravitreal injection.
The ban on OZURDEX set for the receipt of communications from the regulatory authority in the field of quality control of medicines of the Republic of Ireland (Health Products Regulatory Authority) to identify the proportion of silicone in the needle applicator in the series E81083, E80567, E79922, E79891, E79233F, Е79233.Silicone proportion was discovered during the inspection.
Adhering to policies for safe and effective use of our medicines Company Allergan UKRAINE, representing the interests of the applicant and manufacturer Allergan PHARMACEUTICALS IRELAND, Castlebar ROAD, Westport, KO. Mine, IRELAND (ALLERGAN PHARMACEUTICALS IRELAND, CASTLEBAR ROAD, WESTPORT, CO. MAYO, IRELAND) on the territory of Ukraine, always provides complete information about the risks and benefits of our products.
also note that Ukraine has imposed a ban on the drug to thin the blood and for the treatment of macular (Central retinal) edema. On Tuesday, October 2, reported in the Stateservice of Ukraine on drugs and drug control.
So, the country banned tablets Clopidogrel series 20517. The manufacturer of the medication, OOO pilot plant gntsls, Ukraine. Registration certificate – UA/3924/01/01.
The ban was established because of the negative conclusion of the laboratory for quality control of medicines and Zanesville in terms of the Dissolution, Uniformity of metered units. Drug Clopidogrel is used to prevent atherothrombosis in adults.